NCT04008563View on ClinicalTrials.gov

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

March 31, 2027

Conditions
Endometrial CancerAtypical HyperplasiaBariatric Surgery Candidate
Interventions
PROCEDURE

Bariatric Surgery

Patients who are randomized to the intervention group will receive a progestin intrauterine device and be referred for bariatric service to undergo bariatric surgery within 3 months of their study consent.

Trial Locations (1)

M5G 2C4

RECRUITING

Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER